TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $474 | -22.3% | 36,613 | -16.6% | 0.00% | -33.3% |
| Q1 2024 | $610 | -2.9% | 43,901 | -0.2% | 0.00% | 0.0% |
| Q4 2023 | $628 | +4.7% | 43,992 | +13.5% | 0.00% | 0.0% |
| Q3 2023 | $600 | +37.9% | 38,763 | +39.9% | 0.00% | +50.0% |
| Q2 2023 | $435 | +33.8% | 27,710 | +40.6% | 0.00% | 0.0% |
| Q1 2023 | $325 | -25.1% | 19,712 | -29.2% | 0.00% | -33.3% |
| Q4 2022 | $434 | -99.9% | 27,842 | +13.6% | 0.00% | +50.0% |
| Q3 2022 | $318,000 | +5.3% | 24,504 | +14.0% | 0.00% | 0.0% |
| Q2 2022 | $302,000 | +1.0% | 21,496 | +3.0% | 0.00% | 0.0% |
| Q1 2022 | $299,000 | +10.3% | 20,869 | +5.0% | 0.00% | 0.0% |
| Q4 2021 | $271,000 | -31.0% | 19,871 | -17.2% | 0.00% | -33.3% |
| Q3 2021 | $393,000 | -2.2% | 24,005 | +0.6% | 0.00% | 0.0% |
| Q2 2021 | $402,000 | -41.1% | 23,863 | -36.2% | 0.00% | -57.1% |
| Q1 2021 | $683,000 | +13.6% | 37,399 | +13.3% | 0.01% | +16.7% |
| Q4 2020 | $601,000 | +18.1% | 32,995 | +15.6% | 0.01% | 0.0% |
| Q3 2020 | $509,000 | +5.2% | 28,542 | +5.8% | 0.01% | 0.0% |
| Q2 2020 | $484,000 | +13.6% | 26,982 | -3.9% | 0.01% | -14.3% |
| Q1 2020 | $426,000 | +14.8% | 28,074 | +49.4% | 0.01% | +40.0% |
| Q4 2019 | $371,000 | +32.0% | 18,790 | +15.0% | 0.01% | 0.0% |
| Q3 2019 | $281,000 | +10.6% | 16,342 | +13.9% | 0.01% | +25.0% |
| Q2 2019 | $254,000 | +7.6% | 14,347 | +24.0% | 0.00% | 0.0% |
| Q1 2019 | $236,000 | – | 11,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 9,270,535 | $188,841,000 | 39.13% |
| Sachem Head Capital | 5,963,600 | $121,479,000 | 7.38% |
| NINE MASTS CAPITAL Ltd | 1,049,886 | $21,415,000 | 6.68% |
| Paulson & Co. | 26,489,422 | $539,590,000 | 5.77% |
| Blackcrane Capital, LLC | 189,549 | $3,861,000 | 5.16% |
| Glenview Capital Management | 26,112,660 | $531,915,000 | 4.75% |
| Exane Asset Management | 430,369 | $8,766,617,000 | 4.26% |
| Velanne Asset Management Ltd | 281,972 | $5,744,000 | 3.97% |
| Bluefin Trading, LLC | 1,204,702 | $24,540,000 | 3.55% |
| Endurant Capital Management LP | 437,436 | $8,911,000 | 3.52% |